← Back to Clinical Trials
Recruiting NCT07010887

NCT07010887 RHI Interval Effects on Brain Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07010887
Status Recruiting
Phase —
Sponsor Indiana University
Condition Repetitive Head Impacts
Study Type INTERVENTIONAL
Enrollment 102 participants
Start Date 2025-08-05
Primary Completion 2028-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Short IntervalLong IntervalBrainScope qEEG

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 102 participants in total. It began in 2025-08-05 with a primary completion date of 2028-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Military service members frequently experience repetitive insults or impacts to the head (RHIs). The purpose of the proposed randomized controlled trial is to understand how time intervals affect neurological responses to repetitive subconcussive head impacts.

Eligibility Criteria

Inclusion Criteria: * Current soccer player (intercollegiate, club, intramural, recreational). * At least 5 years of soccer heading experience (justification below). * Ability to provide informed consent without a legally authorized representative (LAR). Exclusion Criteria: * Any head, neck, or face injury within the 6 months prior to enrollment, including concussions, that precludes participation in contact sports. * Participants with eye conditions or diseases that could impact the blood vessels in the eye -such as but not limited to: glaucoma, macular degeneration, diabetic retinopathy. * Determination that the participant is unsuitable for study entry or potentially unable to complete all aspects of the study based on the judgement of the Investigator.

Contact & Investigator

Central Contact

Keisuke Kawata, PhD

✉ kkawata@indiana.edu

📞 812-855-5244

Principal Investigator

Keisuke Kawata, PhD

PRINCIPAL INVESTIGATOR

Indiana University Bloomington Department of Kineseology

Frequently Asked Questions

Who can join the NCT07010887 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Repetitive Head Impacts. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07010887 currently recruiting?

Yes, NCT07010887 is actively recruiting participants. Contact the research team at kkawata@indiana.edu for enrollment information.

Where is the NCT07010887 trial being conducted?

This trial is being conducted at Bloomington, United States.

Who is sponsoring the NCT07010887 clinical trial?

NCT07010887 is sponsored by Indiana University. The principal investigator is Keisuke Kawata, PhD at Indiana University Bloomington Department of Kineseology. The trial plans to enroll 102 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology